Sector consensus ICON Public Limited Company

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 09/07/2025 BST			5-day change	1st Jan Change
150.53 ^USD	-0.69%		-0.19%	-28.22%

07-09	Truist Trims Price Target on ICON to $187 From $190, Keeps Buy Rating	MT
05-23	Trump's Tariff Blitz Roils Markets, Targets EU and Apple

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
ICON PUBLIC LIMITED COMPANY	US$176	+16.92%	15
LONZA GROUP AG	CHF 658.11	+16.98%	22
BEONE MEDICINES LTD.	US$330.95	+29.43%	23
CELLTRION, INC.	₩215,974.65	+22.64%	22
IQVIA HOLDINGS INC.	US$190.67	+17.68%	20
EUROFINS SCIENTIFIC SE	€59.73	+0.05%	14
ASCENDIS PHARMA A/S	US$200.66	+33.69%	16
QIAGEN N.V.	US$50.42	+5.13%	15
TEMPUS AI, INC.	US$66.7	+14.19%	10
MEDPACE HOLDINGS, INC.	US$301.61	-6.03%	12
BLUEPRINT MEDICINES CORPORATION	US$130.6	+1.59%	15
BIO-TECHNE CORPORATION	US$67.12	+27.62%	14
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	US$159.67	+0.44%	17
REVOLUTION MEDICINES, INC.	US$72.91	+89.28%	11
IONIS PHARMACEUTICALS, INC.	US$57.89	+35.15%	26
HANGZHOU TIGERMED CONSULTING CO., LTD	CN¥54.42	-5.49%	14
PHARMARON BEIJING CO., LTD.	CN¥29.91	+19.65%	11
TELIX PHARMACEUTICALS LIMITED	A$32.05	+26.23%	8
Average	12,145.23	+19.18%	16
Weighted average by Cap.	23,946.94	+19.12%	18